REED exhibits critical financial distress, highlighted by a Piotroski F-Score of 0/9, indicating the worst possible fundamental health. The company is suffering from a severe contraction in growth, with YoY revenue declining by 23.10%, coupled with catastrophic ROE of -200.54%. Consistent earnings misses (0/4 in the last year) and a 5-year price collapse of 98.8% suggest a failing business model. Despite a single analyst target of $4.75, the deterministic data points toward a high risk of insolvency or further devaluation.